JULY 2014 NEW RELEASE: BONOLIVE® clinical results published in peer reviewed Journal of Nutrition, Health and Ageing
BONOLIVE® increases bone formation biomarkers and improves serum lipid profiles in postmenopausal women with osteopenia.
BONOLIVE® is a clinically proven bone health ingredient. The results of a recent 12 month clinical study in 64 postmenopausal women with osteopenia showed significant effects on bone formation biomarkers and maintenance of a balanced bone turnover process and bone mineral density. Furthermore blood lipid profiles significantly improved, as shown by reduced total and LDL cholesterol and triglyceride levels.
The study was performed by a team of scientists and clinicians from INRA, France and the osteoporosis outpatient clinic of the University Of Lublin, Poland.